|
53
|
156
|
1owaA |
Solution structural studies on human erythrocyte alpha spectrin n terminal tetramerization domain |
|
16
|
76
|
1ncvA |
Determination cc-chemokine mcp-3, nmr, 7 structures |
|
16
|
66
|
1napA |
The crystal structure of recombinant human neutrophil-activating peptide-2 (m6l) at 1.9-angstroms resolution |
|
42
|
128
|
1nbpA |
Crystal structure of human interleukin-2 y31c covalently modified at c31 with 3-mercapto-1-(1,3,4,9-tetrahydro-b-carbolin-2-yl)-propan-1-one |
|
13
|
62
|
1nr2A |
High resolution crystal structures of thymus and activation-regulated chemokine |
|
13
|
67
|
1nr4A |
High resolution crystal structures of thymus and activation-regulated chemokine |
|
32
|
114
|
1mifA |
Macrophage migration inhibitory factor (mif) |
|
45
|
299
|
1n26A |
Crystal structure of the extra-cellular domains of human interleukin-6 receptor alpha chain |
|
9
|
73
|
1mi2A |
Solution structure of murine macrophage inflammatory protein-2, nmr, 20 structures |
|
33
|
114
|
1mffA |
Macrophage migration inhibitory factor y95f mutant |
|
10
|
64
|
1lv9A |
Cxcr3 binding chemokine ip-10/cxcl10 |
|
59
|
172
|
1lkiA |
The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding |
|
43
|
129
|
1m48A |
Crystal structure of human il-2 complexed with (r)-n-[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methyl ester |
|
52
|
142
|
1m4rA |
Crystal structure of recombinant human interleukin-22 |
|
12
|
61
|
1m8aA |
Human mip-3alpha/ccl20 |
|
38
|
126
|
1m4aA |
Crystal structure of human interleukin-2 y31c covalently modified at c31 with (1h-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid |
|
42
|
128
|
1m47A |
Crystal structure of human interleukin-2 |
|
44
|
129
|
1m49A |
Crystal structure of human interleukin-2 complexed with sp-1985 |
|
37
|
129
|
1m4bA |
Crystal structure of human interleukin-2 k43c covalently modified at c43 with 2-[2-(2-cyclohexyl-2-guanidino-acetylamino)-acetylamino]-n-(3-mercapto-propyl)-propionamide |
|
36
|
126
|
1m4cA |
Crystal structure of human interleukin-2 |
|
26
|
144
|
1kxgA |
The 2.0 ang resolution structure of blys, b lymphocyte stimulator. |
|
29
|
155
|
1jtzX |
Crystal structure of trance/rankl cytokine. |
|
46
|
129
|
1hziA |
Interleukin-4 mutant e9a |
|
28
|
151
|
1i1bA |
Crystal structure of recombinant human interleukin-1beta at 2.0 angstroms resolution |
|
17
|
69
|
1icwA |
Interleukin-8, mutant with glu 38 replaced by cys and cys 50 replaced by ala |
|
56
|
167
|
1i1rB |
Crystal structure of a cytokine/receptor complex |
|
55
|
301
|
1i1rA |
Crystal structure of a cytokine/receptor complex |
|
39
|
108
|
1hulA |
A novel dimer configuration revealed by the crystal structure at 2.4 angstroms resolution of human interleukin-5 |
|
24
|
151
|
1hibA |
The structure of an interleukin-1 beta mutant with reduced bioactivity shows multiple subtle changes in conformation that affect protein-protein recognition |
|
45
|
129
|
1hijA |
Interleukin-4 mutant with arg 88 replaced with gln (r88q) |
|
44
|
129
|
1hikA |
Interleukin-4 (wild-type) |
|
34
|
115
|
1gifA |
Human glycosylation-inhibiting factor |
|
8
|
71
|
1g2sA |
Solution structure of eotaxin-3 |
|
12
|
64
|
1f2lA |
Crystal structure of chemokine domain of fractalkine |
|
55
|
306
|
1f42A |
The p40 domain of human interleukin-12 |
|
8
|
65
|
1f9rA |
Crystal structure of platelet factor 4 mutant 1 |
|
15
|
76
|
1esrA |
Crystal structure of human monocyte chemotactic protein-2 |
|
18
|
104
|
1es7A |
Complex between bmp-2 and two bmp receptor ia ectodomains |
|
8
|
74
|
1eotA |
Solution nmr structure of eotaxin, minimized average structure |
|
64
|
184
|
1evsA |
Crystal structure of human oncostatin m |
|
37
|
164
|
1eujA |
A novel anti-tumor cytokine contains a rna-binding motif present in aminoacyl-trna synthetases |
|
31
|
103
|
1fimA |
Macrophage migration inhibitory factor |
|
38
|
134
|
1eteA |
Crystal structure of the flt3 ligand |
|
16
|
86
|
1es7B |
Complex between bmp-2 and two bmp receptor ia ectodomains |
|
25
|
112
|
1jliA |
Human interleukin 3 (il-3) mutant with truncation at both n-and c-termini and 14 residue changes, nmr, minimized average structure |
|
13
|
67
|
1eqtA |
Met-rantes |
|
36
|
212
|
1ernA |
Native structure of the extracellular domain of erythropoietin (epo) receptor [ebp] |
|
10
|
66
|
1f9sA |
Crystal structure of platelet factor 4 mutant 2 |
|
8
|
73
|
1eigA |
Solution structure of the human chemokine eotaxin-2 |
|
12
|
93
|
1j9oA |
Solution structure of human lymphotactin |
